PTEN and glioblastoma: Our previous analysis of PTEN status in our GBM cohort demonstrated 24.32% and 26.66% of PTEN deletion, and 59.45% and 66.66% of PTEN phosphorylation in classical and mesenchymal subtypes, respectively (S5 Fig).